SCHEMBL6010265

SCHEMBL6010265

C[C@H](NOCC(O)CO)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
DUSP3 P51452 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.35
OR51E2 Q9H255 1/20 0.33
TP53 P04637 1/20 0.32
FAAH O00519 1/20 0.32
USP2 O75604 1/20 0.32
TGFBR1 P36897 1/20 0.32
TSHR P16473 2/20 0.31
MAPK1 P28482 1/20 0.31
DGKA P23743 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MME P08473 1/20 0.30
ACE P12821 1/20 0.30
CPA1 P15085 1/20 0.30
ACE2 Q9BYF1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6010216 0.81 KDM4E (0.37) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL1287361 0.79 CYP2D6 (0.34) KDM4ETP53TSHRALDH1A1MME
SCHEMBL6010366 0.79 ALDH1A1 (0.44) MEN1KMT2ALMNAALDH1A1MME
SCHEMBL6009834 0.78 TGFBR1 (0.40) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL6010404 0.78 ALDH1A1 (0.44) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL25706379 0.77 LMNA (0.36) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL19091217 0.77 LMNA (0.36) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL9405945 0.77 LMNA (0.36) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL6009842 0.74 KDM4E (0.40) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL6009597 0.73 ITGB1 (0.33) OR51E2TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117677620-A Antiviral prodrugs of Entecavir (ETV) and formulations thereof 斯克里普斯研究学院 2024-03-08 CN disclosed
CN-116457346-A Preparation of indolone derivatives as novel diacylglycerol O-acyltransferase 2 inhibitors 默沙东有限责任公司 2023-07-18 CN disclosed
US-20060018864-A1 Cosmetic preparation containing glycerylamino acid derivative SEIWA KASEI COMPANY, LIMITED (JP) 2006-01-26 US disclosed
EP-1584320-A1 COSMETIC PREPARATION CONTAINING GLYCERYLAMINO ACID DERIVATIVE Seiwa Kasei Company, Limited (JP) 2005-10-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060018864-A1 Cosmetic preparation containing glycerylamino acid derivative GLA, GPKOW, CUTA KDM4E 3805/4885DUSP3 397/4885MEN1 2277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.